Become A Clinical Trial Volunteer - Touch Another Life
Uh-oh! This study is no longer available.

We're sorry, but the study or condition you’re looking for is no longer available. You can search all currently enrolling studies or contact us if you have any questions.

Type 2 Diabetes – Cardiovascular Disease Risk

Medical Condition

Diabetes (Type 2 Diabetes)

Facility/Clinic

PMG Research of Wilmington

Age

50 or older

Gender

Male/Female

Description

A research study is evaluating whether semaglutide tablets reduce the risk of stroke and heart attack in people with type 2 diabetes.

This research study may be an option if you: 
Have been diagnosed with type 2 diabetes
Have an HbA1c between 6.5 – 10%
Have at least ONE of the following cardiovascular conditions:
- Prior heart attack, stent placement or stenosis 
- History of stroke
- Peripheral Artery Disease (PAD)
- Chronic kidney disease

Other criteria apply.  Please make sure to discuss with a member of our research staff to ensure this research study is a good fit for you.

Qualified participants will receive all study-related care along with regular health and medical testing (including access to glucose testing equipment) at no cost.

Enrollment

Open

Patient Commitment Duration

Approximately 3 – 5 years

Patient Compensation

Participants may be compensated for time and travel.

Number of visits in study

Approximately 26 clinic visits

Apply for this Study Now